Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Capsule | Oral | 250 mg |
| Capsule | Oral | 500 mg |
| Capsule | 250 mg | |
| Capsule, coated | Oral | 250 mg |
| Capsule, coated | Oral | 542 mg |
| Powder, for suspension | Oral | 2.,5 g |
| Powder; syrup | Oral | 62.5 mg/5mL |
| Powder, for suspension | Oral | 125 mg |
| Powder, for suspension | Oral | 2500 mg |
| Powder, for suspension | Oral | 5 g |
| Powder, for suspension | Oral | 5.41 g |
| Powder, for solution | Oral | 5.7375 g |
| Capsule, coated | Oral | 500 mg |
| Suspension | Oral | 2.,5 g |
| Capsule | Oral | 250 mg/1 |
| Capsule | Oral | 500 mg/1 |
| Suspension | Oral | 5 g |
| Tablet, coated | Oral | 250 mg |
| Powder, for suspension | Oral | 62.,5 mg/5mL |
| Powder; syrup | Oral | 125 mg/5mL |
Prices
| Unit description | Cost | Unit |
|---|---|---|
| Dicloxacillin Sodium 500 mg capsule | 1.25USD | capsule |
| Dicloxacillin 500 mg capsule | 1.2USD | capsule |
| Dicloxacillin Sodium 250 mg capsule | 0.,69USD | capsule |
| Dicloxacillin 250 mg capsule | 0.66USD | capsule |
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.
Patents Not Available
Properties
State Solid Experimental Properties
| Property | Value | Source |
|---|---|---|
| water solubility | 3.,63 mg/L | Not Available |
| logP | 2.91 | HANSCH,C ET AL. (1995) |
Predicted Properties
| Property | Value | Source |
|---|---|---|
| Water Solubility | 0.0296 mg/mL | ALOGPS |
| logP | 3.19 | ALOGPS |
| logP | 2.91 | ChemAxon |
| logS | -4.,2 | ALOGPS |
| pKa (Strongest Acidic) | 3.75 | ChemAxon |
| pKa (Strongest Basic) | -0.71 | ChemAxon |
| Physiological Charge | -1 | ChemAxon |
| Hydrogen Acceptor Count | 5 | ChemAxon |
| Hydrogen Donor Count | 2 | ChemAxon |
| Polar Surface Area | 112.74 Å2 | ChemAxon |
| Rotatable Bond Count | 3 | ChemAxon |
| Refractivity | 111.,44 m3·mol-1 | ChemAxon |
| Polarisierbarkeit | 42., | ChemAxon |
| Rule of Five | Yes | ChemAxon |
| Ghose Filter | Yes | ChemAxon |
| Veber’s Rule | No | ChemAxon |
| MDDR-like Rule | No | ChemAxon |
Predicted ADMET Features
| Property | Value | Probability |
|---|---|---|
| Human Intestinal Absorption | + | 0.,8368 |
| Blood Brain Barrier | – | 0.9903 |
| Caco-2 permeable | – | 0.8957 |
| P-glycoprotein substrate | Non-substrate | 0.6204 |
| P-glycoprotein inhibitor I | Non-inhibitor | 0.8951 |
| P-glycoprotein inhibitor II | Non-inhibitor | 0.9204 |
| Renal organic cation transporter | Non-inhibitor | 0.9629 |
| CYP450 2C9 substrate | Non-substrate | 0.,8262 |
| CYP450 2D6 substrate | Non-substrate | 0.905 |
| CYP450 3A4 substrate | Substrate | 0.5977 |
| CYP450 1A2 substrate | Inhibitor | 0.8592 |
| CYP450 2C9 inhibitor | Non-inhibitor | 0.891 |
| CYP450 2D6 inhibitor | Non-inhibitor | 0.918 |
| CYP450 2C19 inhibitor | Non-inhibitor | 0.8832 |
| CYP450 3A4 inhibitor | Non-inhibitor | 0.,819 |
| CYP450 inhibitory promiscuity | Low CYP Inhibitory Promiscuity | 0.9186 |
| Ames test | Non AMES toxic | 0.6979 |
| Carcinogenicity | Carcinogens | 0.5672 |
| Biodegradation | Not ready biodegradable | 1.0 |
| Rat acute toxicity | 1.9946 LD50, mol/kg | Not applicable |
| hERG inhibition (predictor I) | Weak inhibitor | 0.,9996 |
| hERG inhibition (predictor II) | Non-inhibitor | 0.8486 |
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties.,>
Vorhergesagtes LC-MS/MS
Nicht verfügbar
Vorhergesagtes MS/MS Spektrum – 10V, Negativ (mit Anmerkungen versehen)
Vorhergesagtes LC-MS/MS
Nicht verfügbar
Vorhergesagtes MS/MS Spektrum – 20V, Negativ (mit Anmerkungen versehen)
Vorhergesagtes LC-MS/MS
Nicht verfügbar
Vorhergesagte MS/MS Spectrum – 40V, Negativ (mit Anmerkungen versehen)
Vorhergesagte LC-MS/MS
Nicht verfügbar
Ziele
Kind Proteinorganismus Listeria monocytogenes serotype 4b str., LL195 Pharmacological action
Yes
Actions
Inhibitor
General Function Not Available Specific Function Penicillin binding Gene Name pbpC Uniprot ID A0A0E1R3H3 Uniprot Name Penicillin-binding protein 3 Molecular Weight 75015.58 Da
- Gutkind GO, Ogueta SB, de Urtiaga AC, Mollerach ME, de Torres RA: Participation of PBP 3 in the acquisition of dicloxacillin resistance in Listeria monocytogenes. J Antimicrob Chemother. 1990 May;25(5):751-8.,
Kind Protein Organism Streptococcus pneumoniae (strain ATCC BAA-255 / R6) Pharmacological action
Yes
Actions
Inhibitor
General Function Transferase activity, transferring acyl groups Specific Function Not Available Gene Name pbp1b Uniprot ID Q7CRA4 Uniprot Name Penicillin-binding protein 1b Molecular Weight 89479.92 Da
- Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae., Antimicrob Agents Chemother. 1980 Oct;18(4):629-37.
Kind Protein Organism Streptococcus pneumoniae (strain ATCC BAA-255 / R6) Pharmacological action
Yes
Actions
Inhibitor
General Function Transferase activity, transferring acyl groups Specific Function Not Available Gene Name pbp2a Uniprot ID Q8DNB6 Uniprot Name Penicillin-binding protein 2a Molecular Weight 80797.,94 Da
- Williamson R, Hakenbeck R, Tomasz A: In-vivo-Wechselwirkung von beta-lactam-Antibiotika mit penicillin-binding proteins of Streptococcus pneumoniae. Antimikrobielle Mittel Chemother. 1980 Okt;18(4): 629-37.,
Kind Protein Organism Streptococcus pneumoniae Pharmacological action
Yes
Actions
Inhibitor
General Function Serine-type d-ala-d-ala carboxypeptidase activity Specific Function Not Available Gene Name pbp3 Uniprot ID Q75Y35 Uniprot Name Penicillin-binding protein 3 Molecular Weight 45209.84 Da
- Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother., 1980 Oct;18(4):629-37.
Kind Protein Organism Streptococcus pneumoniae (strain ATCC BAA-255 / R6) Pharmacological action
Yes
Actions
Inhibitor
General Function Penicillin binding Specific Function Cell wall formation. Gene Name pbpA Uniprot ID Q8DR59 Uniprot Name Penicillin-binding protein 1A Molecular Weight 79700.9 Da
- Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae., Antimicrob Agents Chemother. 1980 Oct;18(4):629-37.
Kind Protein Organism Streptococcus pneumoniae (strain ATCC BAA-255 / R6) Pharmacological action
Yes
Actions
Inhibitor
General Function Not Available Specific Function Penicillin binding Gene Name penA Uniprot ID P0A3M6 Uniprot Name Penicillin-binding protein 2B Molecular Weight 73872.,305 Da
- Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37.
Enzymes
Kind Protein Organism Humans Pharmacological action
Unknown
Actions
Inducer
General Function Vitamin d3 25-hydroxylase activity Specific Function Cytochromes P450 are a group of heme-thiolate monooxygenases., In Lebermikrosomen ist dieses Enzym an einem NADPH-abhängigen Elektronentransportweg beteiligt. Es führt eine Vielzahl von Oxidationsreaktionen durch… Gen-Namen CYP3A4 Uniprot ID P08684 Uniprot Name Cytochrom-P450-3A4 Molekulargewicht 57342.67 Da
- Yasuda K, Ranade Ein, Venkataramanan R, Strom S, Chupka J, Ekins S, Schuetz E, Bachmann K: Eine umfassende in-vitro-und in-silico-Analyse von Antibiotika, aktivieren pregnane X-rezeptor und induziert CYP3A4 in der Leber und den Darm. Drogen-Metabene. 2008 Aug;36(8):1689-97. doi: 10.1124/dmd.108.020701. Epub 2008 Mai 27.,>
Transporters
Binding Properties
×
| Property | Measurement | pH | Temperature (°C) | |
|---|---|---|---|---|
| Ki (nM) | 7200000 | N/A | N/A | 15567297 / 15974593 |
Details
Binding Properties1., Solute carrier family 15 member 1
Kind Protein Organismus Humans Pharmakologische Wirkung
Unbekannt
Aktionen
Inhibitor
Allgemeine Funktion protonenabhängiges Oligopeptid sekundäre aktive Transmembrantransporteraktivität Spezifische Funktion Protonengekoppelte Aufnahme von Oligopeptiden von 2 bis 4 Aminosäuren mit Präferenz für Dipeptide. Kann einen wichtigen Weg für die Absorption von Proteinverdauungsendprodukten darstellen. Genname SLC15A1 Uniprot ID P46059 Uniprot Name Solute Carrier Familie 15 Mitglied 1 Molekulargewicht 78805.,265 Da
- Luckner P, Brandsch M: Wechselwirkung von 31 Beta-Lactam-Antibiotika mit dem H+ / Peptidsymporter PEPT2: Analyse von Affinitätskonstanten und Vergleich mit PEPT1. Eur J Pharm Biopharm. 2005 Jan;59(1):17-24.,
Binding Properties
×
| Property | Measurement | pH | Temperature (°C) | |
|---|---|---|---|---|
| Ki (nM) | 420000 | N/A | N/A | 21741846 |
Details
Binding Properties2., Gelöste Trägerfamilie 15 member 2
Kind Proteinorganismus Mensch Pharmakologische Wirkung
Unbekannt
Aktionen
Inhibitor
Allgemeines Funktionspeptid: Protonensymportaktivität Spezifische Funktion Protonengekoppelte Aufnahme von Oligopeptiden von 2 bis 4 Aminosäuren mit Präferenz für Dipeptide. Gen Name SLC15A2 Uniprot ID Q16348 Uniprot Name Gelöste träger familie 15 mitglied 2 Molekulargewicht 81782.,77 Da
- Luckner P, Brandsch M: Wechselwirkung von 31 Beta-Lactam-Antibiotika mit dem H+ / Peptidsymporter PEPT2: Analyse von Affinitätskonstanten und Vergleich mit PEPT1. Eur J Pharm Biopharm. 2005 Jan;59(1):17-24.
×
Verbesserung der Patientenergebnisse
Erstellen Sie effektive Tools zur Entscheidungsunterstützung mit dem branchenweit umfassendsten Interaktionsprüfer für Arzneimittel und Arzneimittel.,
Weitere Informationen
reated on June 13, 2005 07: 24 / Updated on January 07, 2021 17: 57
0